We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Why US public health institutions failed so badly and what must be done next time a pandemic hits
Executive signals intention to secure authorisation for infants as young as six months old
Move by Scott Gottlieb adds to sense of ‘revolving door’ between government and industry
Tobacco stocks move lower on fears regulator’s tough push against ecigarettes will continue
Commissioner had locked horns with the tobacco industry over ecigarettes
US regulator also confirms plan to restrict sales of flavoured ecigarette products
US regulator to target tastes such as bubblegum to counter ‘epidemic’ teen use
High prices subject some patients to long-term collateral damage to incomes and health
Spark Therapeutics gets green light in US for blindness treatment that could cost $1m
Rules will help to reduce public’s exposure to addictive drugs, says US commissioner
Top market regulator plans to increase the number of companies it examines
Pharma developments, mosquitoes and malaria, ‘body brokers’
International Edition
